RenovoRx Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for RenovoRx, Inc. (RNXT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-8.81-10.23-9.89-6.32-3.80
Depreciation & Amortization0.000.000.010.710.00
Stock Based Compensation1.171.080.640.150.05
Change in Working Capital0.280.610.43-0.27-0.27
Change in Accounts Payable0.030.030.010.36-0.38
Change in Other Working Capital0.260.580.430.700.11
Other Operating Activities-1.77-1.710.64-0.030.00
Net Cash from Operating Activities-9.13-10.26-8.81-5.92-3.53
Investing Activities
Capital Expenditures-0.010.000.00-0.020.00
Purchases of Investments0.002.03-2.030.000.00
Sales/Maturities of Investments0.002.03-2.03-0.020.00
Other Investing Activities0.000.000.00-0.020.00
Net Cash from Investing Activities-0.012.03-2.03-0.020.00
Financing Activities
Common Stock Issued15.125.000.0414.560.04
Other Financing Activities0.100.000.000.00-0.02
Net Cash from Financing Activities15.125.010.0419.333.20
Summary
Net Change in Cash5.98-3.22-10.8013.40-0.33
Cash at Beginning of Period1.174.3915.191.800.00
Cash at End of Period7.151.174.3915.190.00
Free Cash Flow-9.14-10.26-8.81-5.92-3.53